Quantcast

Case activity for Beverly Clayton vs Teva Pharmaceuticals USA Inc. on Oct. 5

PENNSYLVANIA RECORD

Saturday, November 23, 2024

Case activity for Beverly Clayton vs Teva Pharmaceuticals USA Inc. on Oct. 5

Filings
Shutterstock 376319674

shutterstock.com

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Beverly Clayton against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC., D B a Teva Women's Health, INC., THE Cooper Companies Inc., Teva Pharmaceuticals USA Inc., Teva Women's Health Inc., Individually, and and Teva Women's Health LLC, Individually and on Oct. 5.

'Notice Of Removal By Teva Pharmaceuticals Usa, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva's Women's Health, Inc., Coopersurgical, Inc., The Cooper Companies, Inc, Teva Women's Health Llc F/k/a Teva Women's Health, Inc. (filing Fee $ 400 Receipt Number 0313-14614202), Filed By Teva Pharmaceuticals Usa, Inc., Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc., D/b/a Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva's Women's Health, Inc., Coopersurgical, Inc., The Cooper Companies, Inc, Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Vanguard Group, Inc. By The Cooper Companies, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceuticals Industries Ltd. By Teva Pharmaceuticals Usa, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceuticals Industries Ltd. By Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceuticals Industries Ltd. By Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:20-cv-04904-HB was filed in the U.S. District Court for the Eastern District of Pennsylvania on Oct. 5.

More News